SABCS: I-SPY 3-year pCR results are powerful predictor for breast cancer survival

(King + Company) I-SPY TRIAL for Breast Cancer shows pathological complete response (pCR) predicts event-free/disease-free survival: Findings presented in Oral Presentation at San Antonio Breast Cancer Symposium today by Douglas Yee, MD for Quantum Leap Healthcare Collaborative.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news